In this month´s JADA, the ADA finally chimed in with their guidelines for patients who are on oral bisphosphonates.

Specifically, the ADA stated:

"Relying on a small but growing number of reports linking
bisphosphonate drugs to incidences of osteonecrosis of the jaw (dead
bone tissue), a panel of experts convened by the ADA believes dental
patients who are taking oral bisphosphonate drugs should discuss the
risks they face when undergoing procedures that involve the jaw bone,
such as tooth extraction or placing implants, with their dentist.

Dentists and their patients should carefully consider these procedures,
as well as alternative dental therapies. Patients may also want to
discuss this information in the context of their overall health and
treatment options with their physician.

The ADA
recommends that a comprehensive oral evaluation be carried out on all
patients about to begin therapy with oral bisphosphonates (or as soon
as possible after beginning therapy), and that patients on these drugs
be educated on maintaining oral hygiene, which is the best way to
prevent oral diseases that may require dental surgery.


The ADA notes that dentists, generally, will not need to modify dental
treatments based solely on oral bisphosphonate therapy. Further,
patients should understand that the risk for developing osteonecrosis
of the jaw is considered very small and that the vast majority of
patients taking an oral bisphosphonate do not develop any oral
complication."

Any thoughts on these statements?

Featured Sponsor

Free Daily Email Alert Click Here>>

Get OsseoNews.com Comments delivered daily! Click Here to subscribe.

Leave a Comment

Note: Please refrain from ad hominem attacks, and promotional comments. Outside links are not permitted in comments. Though we require an email to route questionable comments to our editors, we will NEVER publish your email or use it for any other purpose. Thank you for your understanding.

Note: At times your comment may not appear on the website immediately, because it has been sent to our editors for approval. Once approved, we will publish the comment. There is NO need to resubmit your comment, if it does not appear on the website immediately.

Sun July 20 2008

FREE Weekly Email

Keep current on the latest dental implant discussions! It's Free!

>>Click Here to Subscribe to OsseoNews.com Now!